Advertisement

Randomised Controlled Clinical Trials

  • Christopher J. Bulpitt
Book

Table of contents

  1. Front Matter
    Pages i-ix
  2. Christopher J. Bulpitt
    Pages 1-6
  3. Christopher J. Bulpitt
    Pages 7-16
  4. Christopher J. Bulpitt
    Pages 17-43
  5. Christopher J. Bulpitt
    Pages 45-55
  6. Christopher J. Bulpitt
    Pages 57-83
  7. Christopher J. Bulpitt
    Pages 85-112
  8. Christopher J. Bulpitt
    Pages 113-164
  9. Christopher J. Bulpitt
    Pages 165-174
  10. Christopher J. Bulpitt
    Pages 175-181
  11. Christopher J. Bulpitt
    Pages 183-198
  12. Christopher J. Bulpitt
    Pages 199-231
  13. Christopher J. Bulpitt
    Pages 233-243
  14. Christopher J. Bulpitt
    Pages 245-268
  15. Christopher J. Bulpitt
    Pages 269-299
  16. Christopher J. Bulpitt
    Pages 323-330
  17. Christopher J. Bulpitt
    Pages 341-349
  18. Back Matter
    Pages 387-437

About this book

Introduction

After 13 years there are new areas to discuss and more recent trials to be included. Good clinical practice; evaluation of quality of life; measurement of the benefit:risk comparison; determination of cost- effectiveness and cost utility; stopping rules for trials; meta-analysis and subgroup analysis are all new sections. The references are expanded from 305 to 512 and include the recent advances in trial design, such as the n-of-1 trials and megatrials, and up-to-date examples to illustrate the points made in the 20 chapters.

Keywords

drugs evaluation

Authors and affiliations

  • Christopher J. Bulpitt
    • 1
  1. 1.Division of Geriatric MedicineRoyal Postgraduate Medical School Hammersmith HospitalUK

Bibliographic information